latest update:
[TrialBase DB]

trial summary · NCT07031219

HIV/HBV/HCV Triple Screening in Primary Care

Syndemic Triple HIV/HBV/HCV Virus Screening Via EMR Automation at Primary Care Clinics

Trial record from the TrialBase DB dataset, status RECRUITING, condition HIV, sponsored by University of Texas Southwestern Medical Center. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07031219phase —enrollment 50start 2026-11-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Design: This will be a within-subjects repeated-measures design, testing an electronic medical record pop-up alert linked to order panels for screening blood tests for human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). Study participants will be primary care providers. For each participating provider, their encounter will be randomized to either control (no alert; no changes to EMR interface) or an alert with triple-testing order panel intervention arm (alert linked to order panel with screening tests for all three bloodborne viruses (BBVs) selected by default; the alert will be triggered when a provider attempts to order a screening test for at least one BBV). The alert linked to triple testing orders will only be triggered if the provider orders a virus BBV screening test based on their normal practice and standard of care for their patient. Providers will see which orders are selected prior to signing (finalizing) them; therefore, this study will be unblinded. To mitigate the effect of unblinding, randomization will occur at the encounter level which will lead to providers experiencing both the control and intervention conditions randomly throughout the duration of the study. Outcomes/endpoints: The investigators will compare incidences of HIV, HBV, and HCV diagnoses between the two encounter conditions, estimate number of cases missed by not triple-testing, estimate laboratory costs per condition, and measure patient encounters per condition.

Source record: https://clinicaltrials.gov/study/NCT07031219

Facts

registry idNCT07031219
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionHIV
sponsorUniversity of Texas Southwestern Medical Center
sponsor classOTHER
enrollment50
start date2026-11-01
primary completion2027-12-31
completion2027-12-31
results postednot reported

Conditions

  • HIV
  • HBV (Hepatitis B Virus)
  • HCV

Interventions

  • electronic medical record alert linked to orders

Countries

  • United States

Intervention types: OTHER

Work with this record